Medycyna Polskasp. z o.o.

General medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-02-04
Share capital
10,000.00 PLN
Registered address
ul. Bernarda Wapowskiego 1/1, 20-491 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 316 days for 2021). 2 of 6 audited by a statutory auditor.

  • 202506/07/2026
  • 202426/06/2025
  • 202320/03/2024
  • 202201/07/2023
  • 202127/05/2023
  • 202026/07/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 748.66kMedianUSD 766.12kAverageUSD 2.40m
Net profit
This companyUSD -11.96kMedianUSD 38.75kAverageUSD 163.25k
Operating costs
This companyUSD 756.23kMedianUSD 680.38kAverageUSD 2.19m
Assets
This companyUSD 180.81kMedianUSD 261.64kAverageUSD 1.56m

National Health Fund (NFZ) contracts

Medycyna Polska has been an NFZ healthcare provider since 2017. In 2026 it is performing 1 contract worth USD 26.39k. All its contracts were worth USD 223.62k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Primary health carelubelskie1USD 26.39k

Authorized Representatives

Czesław Czyż – Attorney-in-fact
Piotr Czyż – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Piotr Czyżage 45
100$2,701.24100%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $2,917.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$746
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$746
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$730

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

FAQ

Last updated: 2026-10-07